JP2023508491A5 - - Google Patents
Info
- Publication number
- JP2023508491A5 JP2023508491A5 JP2022539641A JP2022539641A JP2023508491A5 JP 2023508491 A5 JP2023508491 A5 JP 2023508491A5 JP 2022539641 A JP2022539641 A JP 2022539641A JP 2022539641 A JP2022539641 A JP 2022539641A JP 2023508491 A5 JP2023508491 A5 JP 2023508491A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962953654P | 2019-12-26 | 2019-12-26 | |
| US62/953,654 | 2019-12-26 | ||
| PCT/US2020/066762 WO2021133866A1 (en) | 2019-12-26 | 2020-12-23 | Compounds for the treatment of myelofibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023508491A JP2023508491A (ja) | 2023-03-02 |
| JPWO2021133866A5 JPWO2021133866A5 (https=) | 2023-12-26 |
| JP2023508491A5 true JP2023508491A5 (https=) | 2023-12-26 |
Family
ID=74186982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539641A Pending JP2023508491A (ja) | 2019-12-26 | 2020-12-23 | 骨髄線維症の治療のための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230062278A1 (https=) |
| EP (1) | EP4081213A1 (https=) |
| JP (1) | JP2023508491A (https=) |
| KR (1) | KR20230005808A (https=) |
| CN (1) | CN115697323A (https=) |
| AU (1) | AU2020415440A1 (https=) |
| BR (1) | BR112022012819A2 (https=) |
| CA (1) | CA3166251A1 (https=) |
| IL (1) | IL294369A (https=) |
| MX (1) | MX2022008046A (https=) |
| WO (1) | WO2021133866A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2673368C (en) * | 2006-12-19 | 2014-10-28 | The Board Of Trustees Of The University Of Illinois | 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
| CN113384546A (zh) * | 2012-11-15 | 2021-09-14 | 因赛特公司 | 鲁索利替尼的缓释剂型 |
| WO2015081127A2 (en) * | 2013-11-26 | 2015-06-04 | Gilead Sciences, Inc. | Therapies for treating myeloproliferative disorders |
| CN106349224A (zh) * | 2016-08-03 | 2017-01-25 | 山东大学 | 一种含有4‑氨基‑(1h)‑吡唑结构的jak激酶抑制剂及其制备方法和应用 |
| WO2019222483A1 (en) * | 2018-05-17 | 2019-11-21 | Board Of Regents, The University Of Texas System | Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form beta inhibitors |
| CN112351819B (zh) * | 2018-06-05 | 2023-11-10 | 开动疗法公司 | 治疗恶性淋巴增生性疾病的方法 |
-
2020
- 2020-12-23 AU AU2020415440A patent/AU2020415440A1/en not_active Abandoned
- 2020-12-23 MX MX2022008046A patent/MX2022008046A/es unknown
- 2020-12-23 EP EP20842523.1A patent/EP4081213A1/en not_active Withdrawn
- 2020-12-23 US US17/789,321 patent/US20230062278A1/en not_active Abandoned
- 2020-12-23 BR BR112022012819A patent/BR112022012819A2/pt not_active Application Discontinuation
- 2020-12-23 WO PCT/US2020/066762 patent/WO2021133866A1/en not_active Ceased
- 2020-12-23 IL IL294369A patent/IL294369A/en unknown
- 2020-12-23 KR KR1020227025801A patent/KR20230005808A/ko not_active Withdrawn
- 2020-12-23 CN CN202080094791.2A patent/CN115697323A/zh active Pending
- 2020-12-23 CA CA3166251A patent/CA3166251A1/en active Pending
- 2020-12-23 JP JP2022539641A patent/JP2023508491A/ja active Pending